Lurbinectedin in small cell lung cancer

Few treatment options are available for patients with small cell lung cancer (SCLC) in progression after a first-line therapy. A novel therapeutic approach is represented by lurbinectedin, a synthetic derivative of trabectedin that works by inhibiting oncogenic transcription and promoting apoptosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Manzo, Anna, Sforza, Vincenzo, Carillio, Guido, Palumbo, Giuliano, Montanino, Agnese, Sandomenico, Claudia, Costanzo, Raffaele, Esposito, Giovanna, Laudato, Francesca, Mercadante, Edoardo, La Manna, Carmine, Muto, Paolo, Totaro, Giuseppe, De Cecio, Rossella, Picone, Carmine, Piccirillo, Maria Carmela, Pascarella, Giacomo, Normanno, Nicola, Morabito, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469650/
https://www.ncbi.nlm.nih.gov/pubmed/36110944
http://dx.doi.org/10.3389/fonc.2022.932105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469650/
https://www.ncbi.nlm.nih.gov/pubmed/36110944
http://dx.doi.org/10.3389/fonc.2022.932105

Ejemplares similares